Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, B-Cell × Alemtuzumab × 90 days × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Clear Cell 1

Interventions

Cyclophosphamide 5 fludarabine phosphate 3 fludarabine 3 Mycophenolic Acid 3 Mesna 3 Melphalan 3 ibrutinib 2 acalabrutinib 2 Whole-Body Irradiation 2 Tacrolimus 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Busulfan 2 Bone Marrow Transplantation 2 ricolinostat 1 pirtobrutinib 1 obinutuzumab 1 idelalisib 1 idecabtagene vicleucel 1 Vincristine 1 Stem Cell Transplantation 1 Prednisone 1 Leukapheresis 1 Filgrastim 1 Doxorubicin 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡